(Q41042255)

26 September 2017

Interferon-beta-1-b (IFN-B) decreases induced nitric oxide (NO) production by a human astrocytoma cell line (English)

1 reference

26 September 2017

1 reference

Guthikonda P

1

1 reference

PubMed ID

9585809

26 September 2017

Baker J

series ordinal

2

1 reference

PubMed ID

9585809

26 September 2017

Mattson DH

series ordinal

3

1 reference

26 September 2017

1 March 1998

1 reference

Journal of Neuroimmunology

26 September 2017

1 reference

26 September 2017

82

1 reference

26 September 2017

2

1 reference

26 September 2017

133-139

1 reference

Suppression of lymphocyte proliferation through the nitric oxide synthesizing pathway

26 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

7 January 2021

Interferon beta in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

7 January 2021

Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

7 January 2021

Reactive nitrogen intermediates in human neuropathology: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

7 January 2021

Cytokine localization in multiple sclerosis lesions: correlation with adhesion molecule expression and reactive nitrogen species

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

7 January 2021

Regulation of inducible nitric oxide synthase mRNA levels by LPS, INF-gamma, TGF-beta, and IL-10 in murine macrophage cell lines and rat peritoneal macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

7 January 2021

Interferon beta for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

7 January 2021

Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

7 January 2021

Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-gamma in murine macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

7 January 2021

Multiple cytokines are required to induce hepatocyte nitric oxide production and inhibit total protein synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

7 January 2021

Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

7 January 2021

Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

7 January 2021

Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

7 January 2021

Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

7 January 2021

MS: a CNS and systemic autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

7 January 2021

Multiple sclerosis: immunological findings and possible implications for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

7 January 2021

Tumor necrosis factor identified in multiple sclerosis brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

7 January 2021

Cloning and functional expression of human inducible nitric oxide synthase (NOS) cDNA from a glioblastoma cell line A-172.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

7 January 2021

Interferon beta-1b reduces interferon gamma-induced antigen-presenting capacity of human glial and B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

7 January 2021

Evidence for increased nitric oxide production in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

7 January 2021

Suppression of low dose streptozotocin induced diabetes in mice by administration of a nitric oxide synthase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

7 January 2021

Nitric oxide: a pathogenetic factor in autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

7 January 2021

Nitric oxide--a new endogenous immunomodulator.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

7 January 2021

Induction of nitric oxide synthase activity in human astrocytes by interleukin-1 beta and interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

7 January 2021

Regulation of nitric oxide synthesis in infectious and autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

7 January 2021

Regulation of lymphocyte functions by nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

7 January 2021

A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

7 January 2021

Nitric oxide, a novel biologic messenger

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

7 January 2021

Inhibition of nitric oxide generation affects the induction of diabetes by streptozocin in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

7 January 2021

Selective inhibition of the inducible nitric oxide synthase by aminoguanidine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

7 January 2021

Nitric oxide as a potential pathological mechanism in demyelination: its differential effects on primary glial cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

7 January 2021

Cytokine-induced nitric oxide generation by cultured astrocytoma cells involves Ca(++)-calmodulin-independent NO-synthase.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

7 January 2021

Nitric oxide as a secretory product of mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

7 January 2021

Contrasting effects of alpha, beta, and gamma interferons on nonspecific suppressor function in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

7 January 2021

Interferon beta decreases T cell activation and interferon gamma production in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

7 January 2021

Inflammation, immunoregulation, and inducible nitric oxide synthase.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

7 January 2021

Glucocorticoids inhibit the induction of nitric oxide synthase and the related cell damage in adenocarcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

7 January 2021

Expression of the inducible isoform of nitric oxide synthase in the central nervous system of mice correlates with the severity of actively induced experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

7 January 2021

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

7 January 2021

Interferon effects on interleukin-10 secretion. Mononuclear cell response to interleukin-10 is normal in multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

7 January 2021

A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

7 January 2021

Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

7 January 2021

Availability of tetrahydrobiopterin is not a factor in the inability to detect nitric oxide production by human macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

1 reference

7 January 2021

Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

7 January 2021

Nitric oxide-mediated neuronal injury in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

7 January 2021

Induction of nitric oxide synthase in glial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

7 January 2021

Multiple sclerosis: involvement of interferons in lesion pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

7 January 2021

Rationale for immunotherapy in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

7 January 2021

Cytokine production in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

7 January 2021

Human monocytes are stimulated for nitric oxide release in vitro by some tumor cells but not by cytokines and lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

7 January 2021

Production of nitrite by neonatal rat microglial cells/brain macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900172-0

7 January 2021

10.1016/S0165-5728(97)00172-0

Identifiers

DOI

1 reference

26 September 2017

1 reference

PubMed ID

9585809